A Nomogram Based on Serum Biomarkers and Clinical Characteristics to Predict Survival in Patients With Non-Metastatic Nasopharyngeal Carcinoma
This study focused on developing an effective nomogram for improving prognostication for patients with primary nasopharyngeal carcinoma (NPC) restaged according to the eighth edition of the AJCC/UICC TNM staging system. Based on data of 5,903 patients with non-metastatic NPC (primary cohort), we use...
Saved in:
Published in | Frontiers in oncology Vol. 10; p. 594363 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Switzerland
Frontiers Media S.A
10.12.2020
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | This study focused on developing an effective nomogram for improving prognostication for patients with primary nasopharyngeal carcinoma (NPC) restaged according to the eighth edition of the AJCC/UICC TNM staging system.
Based on data of 5,903 patients with non-metastatic NPC (primary cohort), we used Cox regression analysis to identify survival risk factors and created a nomogram. We used the nomogram to predict overall survival (OS), distant metastasis-free survival (DMFS) and disease-free survival (DFS) in the primary and independent validation (3,437 patients) cohorts. Moreover, we compared the prognostic accuracy between the 8th TNM system and the nomogram.
The nomogram included gender, age, T stage, N stage, Epstein-Barr virus DNA, hemoglobin, C-reactive protein, lactate dehydrogenase, and radiotherapy with/without induction or concurrent chemotherapy. In the prediction of OS, DMFS and DFS, the nomogram had significantly higher concordance index (C-index) and area under ROC curve (AUC) than the TNM system alone. Calibration curves demonstrated satisfactory agreements between nomogram-predicted and observed survival. The stratification in different groups permitted remarkable differentiation among Kaplan-Meier curves for OS, DMFS, and DFS.
The nomogram led to a more precise prognostic prediction for NPC patients in comparison with the 8th TNM system. Therefore, it could facilitate individualized and personalized patients' counseling and care. |
---|---|
AbstractList | ObjectiveThis study focused on developing an effective nomogram for improving prognostication for patients with primary nasopharyngeal carcinoma (NPC) restaged according to the eighth edition of the AJCC/UICC TNM staging system.MethodsBased on data of 5,903 patients with non-metastatic NPC (primary cohort), we used Cox regression analysis to identify survival risk factors and created a nomogram. We used the nomogram to predict overall survival (OS), distant metastasis-free survival (DMFS) and disease-free survival (DFS) in the primary and independent validation (3,437 patients) cohorts. Moreover, we compared the prognostic accuracy between the 8th TNM system and the nomogram.ResultsThe nomogram included gender, age, T stage, N stage, Epstein–Barr virus DNA, hemoglobin, C-reactive protein, lactate dehydrogenase, and radiotherapy with/without induction or concurrent chemotherapy. In the prediction of OS, DMFS and DFS, the nomogram had significantly higher concordance index (C-index) and area under ROC curve (AUC) than the TNM system alone. Calibration curves demonstrated satisfactory agreements between nomogram-predicted and observed survival. The stratification in different groups permitted remarkable differentiation among Kaplan–Meier curves for OS, DMFS, and DFS.ConclusionThe nomogram led to a more precise prognostic prediction for NPC patients in comparison with the 8th TNM system. Therefore, it could facilitate individualized and personalized patients’ counseling and care. This study focused on developing an effective nomogram for improving prognostication for patients with primary nasopharyngeal carcinoma (NPC) restaged according to the eighth edition of the AJCC/UICC TNM staging system.OBJECTIVEThis study focused on developing an effective nomogram for improving prognostication for patients with primary nasopharyngeal carcinoma (NPC) restaged according to the eighth edition of the AJCC/UICC TNM staging system.Based on data of 5,903 patients with non-metastatic NPC (primary cohort), we used Cox regression analysis to identify survival risk factors and created a nomogram. We used the nomogram to predict overall survival (OS), distant metastasis-free survival (DMFS) and disease-free survival (DFS) in the primary and independent validation (3,437 patients) cohorts. Moreover, we compared the prognostic accuracy between the 8th TNM system and the nomogram.METHODSBased on data of 5,903 patients with non-metastatic NPC (primary cohort), we used Cox regression analysis to identify survival risk factors and created a nomogram. We used the nomogram to predict overall survival (OS), distant metastasis-free survival (DMFS) and disease-free survival (DFS) in the primary and independent validation (3,437 patients) cohorts. Moreover, we compared the prognostic accuracy between the 8th TNM system and the nomogram.The nomogram included gender, age, T stage, N stage, Epstein-Barr virus DNA, hemoglobin, C-reactive protein, lactate dehydrogenase, and radiotherapy with/without induction or concurrent chemotherapy. In the prediction of OS, DMFS and DFS, the nomogram had significantly higher concordance index (C-index) and area under ROC curve (AUC) than the TNM system alone. Calibration curves demonstrated satisfactory agreements between nomogram-predicted and observed survival. The stratification in different groups permitted remarkable differentiation among Kaplan-Meier curves for OS, DMFS, and DFS.RESULTSThe nomogram included gender, age, T stage, N stage, Epstein-Barr virus DNA, hemoglobin, C-reactive protein, lactate dehydrogenase, and radiotherapy with/without induction or concurrent chemotherapy. In the prediction of OS, DMFS and DFS, the nomogram had significantly higher concordance index (C-index) and area under ROC curve (AUC) than the TNM system alone. Calibration curves demonstrated satisfactory agreements between nomogram-predicted and observed survival. The stratification in different groups permitted remarkable differentiation among Kaplan-Meier curves for OS, DMFS, and DFS.The nomogram led to a more precise prognostic prediction for NPC patients in comparison with the 8th TNM system. Therefore, it could facilitate individualized and personalized patients' counseling and care.CONCLUSIONThe nomogram led to a more precise prognostic prediction for NPC patients in comparison with the 8th TNM system. Therefore, it could facilitate individualized and personalized patients' counseling and care. This study focused on developing an effective nomogram for improving prognostication for patients with primary nasopharyngeal carcinoma (NPC) restaged according to the eighth edition of the AJCC/UICC TNM staging system. Based on data of 5,903 patients with non-metastatic NPC (primary cohort), we used Cox regression analysis to identify survival risk factors and created a nomogram. We used the nomogram to predict overall survival (OS), distant metastasis-free survival (DMFS) and disease-free survival (DFS) in the primary and independent validation (3,437 patients) cohorts. Moreover, we compared the prognostic accuracy between the 8th TNM system and the nomogram. The nomogram included gender, age, T stage, N stage, Epstein-Barr virus DNA, hemoglobin, C-reactive protein, lactate dehydrogenase, and radiotherapy with/without induction or concurrent chemotherapy. In the prediction of OS, DMFS and DFS, the nomogram had significantly higher concordance index (C-index) and area under ROC curve (AUC) than the TNM system alone. Calibration curves demonstrated satisfactory agreements between nomogram-predicted and observed survival. The stratification in different groups permitted remarkable differentiation among Kaplan-Meier curves for OS, DMFS, and DFS. The nomogram led to a more precise prognostic prediction for NPC patients in comparison with the 8th TNM system. Therefore, it could facilitate individualized and personalized patients' counseling and care. |
Author | Li, Qing-Jie Mao, Yan-Ping Guo, Rui Huang, Cheng-Long Chen, Lei Fang, Xue-Liang Ma, Jun Tang, Ling-Long |
AuthorAffiliation | Department of Radiation Oncology, Sun Yat-sen University Cancer Center , Guangzhou , China |
AuthorAffiliation_xml | – name: Department of Radiation Oncology, Sun Yat-sen University Cancer Center , Guangzhou , China |
Author_xml | – sequence: 1 givenname: Qing-Jie surname: Li fullname: Li, Qing-Jie – sequence: 2 givenname: Yan-Ping surname: Mao fullname: Mao, Yan-Ping – sequence: 3 givenname: Rui surname: Guo fullname: Guo, Rui – sequence: 4 givenname: Cheng-Long surname: Huang fullname: Huang, Cheng-Long – sequence: 5 givenname: Xue-Liang surname: Fang fullname: Fang, Xue-Liang – sequence: 6 givenname: Jun surname: Ma fullname: Ma, Jun – sequence: 7 givenname: Ling-Long surname: Tang fullname: Tang, Ling-Long – sequence: 8 givenname: Lei surname: Chen fullname: Chen, Lei |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/33363024$$D View this record in MEDLINE/PubMed |
BookMark | eNp1Uk1v1DAQjVARLaV3TshHLln8mTgXpLLio1IplVoJbpZjT3ZdsvbWdlbqn-A347ClapHwxZ7xm_dmNO9ldeCDh6p6TfCCMdm9G4I3C4opXoiOs4Y9q44oZbwuwY-DR-_D6iSlG1xOIzDB7EV1yFjBY8qPql-n6CJswirqDfqgE1gUPLqCOJXQhY2OPyEmpL1Fy9F5Z_SIlmsdtckQXcrOJJQDuoxgncnoaoo7tysY59Glzg58Tui7y-si4uuvkHXKJW3QhU5hW3ju_ApmSh2N80XuVfV80GOCk_v7uLr-9PF6-aU-__b5bHl6Xhve0FyTru061jPKmNAUSDNg2Q64aY3FAxUDaMaF4LKnkvaS2EESOlhhhbTQMsGOq7M9rQ36Rm2jK4PeqaCd-pMIcaV0LH2OoHreEsY70kKD-aC7DhuKrel72RMKfVu43u-5tlO_AWvKzFGPT0if_ni3VquwU20rJO9kIXh7TxDD7QQpq41LBsZRewhTUpS3jGMhm6ZA3zzWehD5u88CwHuAiSGlCMMDhGA1u0bNrlGza9TeNaWk-afEuHlJYe7Wjf8v_A2OS8lO |
CitedBy_id | crossref_primary_10_1016_j_radonc_2023_109629 crossref_primary_10_3389_fonc_2021_683475 crossref_primary_10_1007_s00432_023_04952_3 crossref_primary_10_1007_s10278_024_01109_7 crossref_primary_10_1038_s41598_024_59131_2 crossref_primary_10_1371_journal_pone_0309436 crossref_primary_10_1007_s00066_022_01926_1 crossref_primary_10_1186_s12935_021_02158_6 crossref_primary_10_2217_fon_2021_1121 crossref_primary_10_1016_j_currproblcancer_2022_100897 crossref_primary_10_1186_s12885_023_11117_5 crossref_primary_10_1038_s41598_022_16216_0 crossref_primary_10_3389_fonc_2021_715635 |
Cites_doi | 10.1093/jnci/dji084 10.1200/JCO.2012.41.5984 10.1038/s41588-019-0436-5 10.1098/rstb.2016.0270 10.1007/s13277-015-4042-6 10.1038/bjc.2013.659 10.1111/coa.13454 10.1016/s1535-6108(04)00119-9 10.1200/JCO.2002.08.149 10.5732/cjc.011.10283 10.1200/JCO.2010.33.7741 10.1002/cncr.27853 10.3322/caac.21492 10.1200/JCO.2009.25.6552 10.1016/S0140-6736(05)66698-6 10.3389/fonc.2019.00089 10.1093/jnci/djr432 10.1016/j.clon.2013.07.004 10.1586/1744666X.4.3.379 10.1016/j.oraloncology.2014.02.006 10.1016/j.oraloncology.2017.07.011 10.1002/hed.23357 10.1186/s12885-018-4419-1 10.1016/j.oraloncology.2019.05.015 10.1016/j.ijrobp.2014.10.005 10.1016/S0140-6736(16)31388-5 10.1200/JCO.2007.12.9791 10.1016/j.ijrobp.2011.05.009 10.1016/j.ijrobp.2006.07.012 10.1016/j.ejca.2013.03.008 10.1001/jamasurg.2015.4516 |
ContentType | Journal Article |
Copyright | Copyright © 2020 Li, Mao, Guo, Huang, Fang, Ma, Tang and Chen. Copyright © 2020 Li, Mao, Guo, Huang, Fang, Ma, Tang and Chen 2020 Li, Mao, Guo, Huang, Fang, Ma, Tang and Chen |
Copyright_xml | – notice: Copyright © 2020 Li, Mao, Guo, Huang, Fang, Ma, Tang and Chen. – notice: Copyright © 2020 Li, Mao, Guo, Huang, Fang, Ma, Tang and Chen 2020 Li, Mao, Guo, Huang, Fang, Ma, Tang and Chen |
DBID | AAYXX CITATION NPM 7X8 5PM DOA |
DOI | 10.3389/fonc.2020.594363 |
DatabaseName | CrossRef PubMed MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef PubMed MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic PubMed |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals - NZ url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 2234-943X |
ExternalDocumentID | oai_doaj_org_article_b47134917e604fa990c20dcbb8b12eb7 PMC7758498 33363024 10_3389_fonc_2020_594363 |
Genre | Journal Article |
GrantInformation_xml | – fundername: Overseas Expertise Introduction Project for Discipline Innovation grantid: 111 Project, B14035 – fundername: Natural Science Foundation of Guangdong Province grantid: 2017A030312003 – fundername: National Natural Science Foundation of China grantid: 81930072 |
GroupedDBID | 53G 5VS 9T4 AAFWJ AAKDD AAYXX ACGFO ACGFS ACXDI ADBBV ADRAZ AFPKN ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BCNDV CITATION DIK EBS EJD EMOBN GROUPED_DOAJ GX1 HYE KQ8 M48 M~E OK1 PGMZT RNS RPM IPNFZ NPM RIG 7X8 5PM |
ID | FETCH-LOGICAL-c462t-197993b32335a2e16f087f067cd0f25fea345548b282b81df812fd5d58de7353 |
IEDL.DBID | M48 |
ISSN | 2234-943X |
IngestDate | Wed Aug 27 01:26:19 EDT 2025 Thu Aug 21 18:04:13 EDT 2025 Fri Jul 11 09:21:31 EDT 2025 Mon Jul 21 05:47:37 EDT 2025 Tue Jul 01 04:37:52 EDT 2025 Thu Apr 24 22:59:52 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Keywords | prognostic prediction nasopharyngeal carcinoma nomogram serum biomarkers survival |
Language | English |
License | Copyright © 2020 Li, Mao, Guo, Huang, Fang, Ma, Tang and Chen. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c462t-197993b32335a2e16f087f067cd0f25fea345548b282b81df812fd5d58de7353 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 This article was submitted to Head and Neck Cancer, a section of the journal Frontiers in Oncology Edited by: Fan Zhang, Fifth Affiliated Hospital of Sun Yat-sen University, China These authors have contributed equally to this work Reviewed by: Lina Zhao, Fourth Military Medical University, China; Shao-Bo Liang, First People’s Hospital of Foshan, China; Yufeng Ren, First Affiliated Hospital of Sun Yat-Sen University, China |
OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.3389/fonc.2020.594363 |
PMID | 33363024 |
PQID | 2473405866 |
PQPubID | 23479 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_b47134917e604fa990c20dcbb8b12eb7 pubmedcentral_primary_oai_pubmedcentral_nih_gov_7758498 proquest_miscellaneous_2473405866 pubmed_primary_33363024 crossref_primary_10_3389_fonc_2020_594363 crossref_citationtrail_10_3389_fonc_2020_594363 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2020-12-10 |
PublicationDateYYYYMMDD | 2020-12-10 |
PublicationDate_xml | – month: 12 year: 2020 text: 2020-12-10 day: 10 |
PublicationDecade | 2020 |
PublicationPlace | Switzerland |
PublicationPlace_xml | – name: Switzerland |
PublicationTitle | Frontiers in oncology |
PublicationTitleAlternate | Front Oncol |
PublicationYear | 2020 |
Publisher | Frontiers Media S.A |
Publisher_xml | – name: Frontiers Media S.A |
References | Xu (B21) 2010; 28 Tang (B13) 2015; 91 Wang (B22) 2011; 29 Chen (B30) 2019; 9 Wang (B25) 2013; 119 Gao (B26) 2012; 82 Bray (B4) 2018; 68 OuYang (B8) 2017; 72 Chan (B5) 2002; 20 Yang (B28) 2020; 45 Wei (B1) 2005; 365 Zhang (B6) 2016; 388 Kim (B16) 2016; 151 Xu (B23) 2019; 51 Tsao (B10) 2017; 372 Wang (B15) 2013; 31 Li (B12) 2014; 36 Chen (B20) 2011; 103 Lo (B2) 2004; 5 Chang (B11) 2013; 25 Twu (B24) 2007; 67 Tsao (B3) 2014; 50 Yang (B9) 2018; 18 OuYang (B7) 2013; 109 Iasonos (B18) 2008; 26 Wan (B31) 2013; 49 Chan (B19) 2005; 97 Li (B14) 2012; 31 Peisajovich (B29) 2008; 4 Zhang (B27) 2016; 37 Sun (B17) 2019; 94 |
References_xml | – volume: 97 year: 2005 ident: B19 article-title: Overall survival after concurrent cisplatin-radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma publication-title: J Natl Cancer Inst doi: 10.1093/jnci/dji084 – volume: 31 year: 2013 ident: B15 article-title: Prognostic nomogram for intrahepatic cholangiocarcinoma after partial hepatectomy publication-title: J Clin Oncol doi: 10.1200/JCO.2012.41.5984 – volume: 51 year: 2019 ident: B23 article-title: Genome sequencing analysis identifies Epstein-Barr virus subtypes associated with high risk of nasopharyngeal carcinoma publication-title: Nat Genet doi: 10.1038/s41588-019-0436-5 – volume: 372 start-page: 20160270 year: 2017 ident: B10 article-title: Epstein-Barr virus infection and nasopharyngeal carcinoma publication-title: Philos Trans R Soc Lond B Biol Sci doi: 10.1098/rstb.2016.0270 – volume: 37 year: 2016 ident: B27 article-title: Pretreatment anemia and survival in nasopharyngeal carcinoma publication-title: Tumour Biol doi: 10.1007/s13277-015-4042-6 – volume: 109 year: 2013 ident: B7 article-title: Comparison of TNM staging systems for nasopharyngeal carcinoma, and proposal of a new staging system publication-title: Br J Cancer doi: 10.1038/bjc.2013.659 – volume: 45 year: 2020 ident: B28 article-title: Prognostic role of pre-treatment serum albumin in patients with nasopharyngeal carcinoma: A meta-analysis and systematic review publication-title: Clin Otolaryngol doi: 10.1111/coa.13454 – volume: 5 year: 2004 ident: B2 article-title: Focus on nasopharyngeal carcinoma publication-title: Cancer Cell doi: 10.1016/s1535-6108(04)00119-9 – volume: 20 year: 2002 ident: B5 article-title: Concurrent chemotherapy-radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: progression-free survival analysis of a phase III randomized trial publication-title: J Clin Oncol doi: 10.1200/JCO.2002.08.149 – volume: 31 start-page: 197 year: 2012 ident: B14 article-title: Increased pretreatment levels of serum LDH and ALP as poor prognostic factors for nasopharyngeal carcinoma publication-title: Chin J Cancer doi: 10.5732/cjc.011.10283 – volume: 29 year: 2011 ident: B22 article-title: Eight-signature classifier for prediction of nasopharyngeal [corrected] carcinoma survival publication-title: J Clin Oncol doi: 10.1200/JCO.2010.33.7741 – volume: 119 year: 2013 ident: B25 article-title: Long-term survival analysis of nasopharyngeal carcinoma by plasma Epstein-Barr virus DNA levels publication-title: Cancer doi: 10.1002/cncr.27853 – volume: 68 start-page: 394 year: 2018 ident: B4 article-title: Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries publication-title: CA Cancer J Clin doi: 10.3322/caac.21492 – volume: 28 year: 2010 ident: B21 article-title: Serologic antienzyme rate of Epstein-Barr virus DNase-specific neutralizing antibody segregates TNM classification in nasopharyngeal carcinoma publication-title: J Clin Oncol doi: 10.1200/JCO.2009.25.6552 – volume: 365 year: 2005 ident: B1 article-title: Nasopharyngeal carcinoma publication-title: Lancet doi: 10.1016/S0140-6736(05)66698-6 – volume: 9 year: 2019 ident: B30 article-title: Effect of CRP and Kinetics of CRP in Prognosis of Nasopharyngeal Carcinoma publication-title: Front Oncol doi: 10.3389/fonc.2019.00089 – volume: 103 year: 2011 ident: B20 article-title: Concurrent chemoradiotherapy vs radiotherapy alone in stage II nasopharyngeal carcinoma: phase III randomized trial publication-title: J Natl Cancer Inst doi: 10.1093/jnci/djr432 – volume: 25 year: 2013 ident: B11 article-title: Haemoglobin, neutrophil to lymphocyte ratio and platelet count improve prognosis prediction of the TNM staging system in nasopharyngeal carcinoma: development and validation in 3,237 patients from a single institution publication-title: Clin Oncol (R Coll Radiol) doi: 10.1016/j.clon.2013.07.004 – volume: 4 year: 2008 ident: B29 article-title: Du Clos TW. C-reactive protein at the interface between innate immunity and inflammation publication-title: Expert Rev Clin Immunol doi: 10.1586/1744666X.4.3.379 – volume: 50 year: 2014 ident: B3 article-title: Etiological factors of nasopharyngeal carcinoma publication-title: Oral Oncol doi: 10.1016/j.oraloncology.2014.02.006 – volume: 72 start-page: 65 year: 2017 ident: B8 article-title: Validation and comparison of the 7th and 8th edition of AJCC staging systems for non-metastatic nasopharyngeal carcinoma, and proposed staging systems from Hong Kong, Guangzhou, and Guangxi publication-title: Oral Oncol doi: 10.1016/j.oraloncology.2017.07.011 – volume: 36 year: 2014 ident: B12 article-title: Influence of pretreatment ideal body weight percentile and albumin on prognosis of nasopharyngeal carcinoma: Long-term outcomes of 512 patients from a single institution publication-title: Head Neck doi: 10.1002/hed.23357 – volume: 18 start-page: 606 year: 2018 ident: B9 article-title: Comparison of the seventh and eighth editions of the UICC/AJCC staging system for nasopharyngeal carcinoma: analysis of 1317 patients treated with intensity-modulated radiotherapy at two centers publication-title: BMC Cancer doi: 10.1186/s12885-018-4419-1 – volume: 94 year: 2019 ident: B17 article-title: Establishment and validation of a nomogram for predicting survival in patients with de novo metastatic nasopharyngeal carcinoma publication-title: Oral Oncol doi: 10.1016/j.oraloncology.2019.05.015 – volume: 91 year: 2015 ident: B13 article-title: High-sensitivity C-reactive protein complements plasma Epstein-Barr virus deoxyribonucleic acid prognostication in nasopharyngeal carcinoma: a large-scale retrospective and prospective cohort study publication-title: Int J Radiat Oncol Biol Phys doi: 10.1016/j.ijrobp.2014.10.005 – volume: 388 year: 2016 ident: B6 article-title: Gemcitabine plus cisplatin versus fluorouracil plus cisplatin in recurrent or metastatic nasopharyngeal carcinoma: a multicentre, randomised, open-label, phase 3 trial publication-title: Lancet doi: 10.1016/S0140-6736(16)31388-5 – volume: 26 year: 2008 ident: B18 article-title: How to build and interpret a nomogram for cancer prognosis publication-title: J Clin Oncol doi: 10.1200/JCO.2007.12.9791 – volume: 82 year: 2012 ident: B26 article-title: Involvement of difference in decrease of hemoglobin level in poor prognosis of Stage I and II nasopharyngeal carcinoma: implication in outcome of radiotherapy publication-title: Int J Radiat Oncol Biol Phys doi: 10.1016/j.ijrobp.2011.05.009 – volume: 67 year: 2007 ident: B24 article-title: Comparison of the prognostic impact of serum anti-EBV antibody and plasma EBV DNA assays in nasopharyngeal carcinoma publication-title: Int J Radiat Oncol Biol Phys doi: 10.1016/j.ijrobp.2006.07.012 – volume: 49 year: 2013 ident: B31 article-title: High pretreatment serum lactate dehydrogenase level correlates with disease relapse and predicts an inferior outcome in locally advanced nasopharyngeal carcinoma publication-title: Eur J Cancer doi: 10.1016/j.ejca.2013.03.008 – volume: 151 year: 2016 ident: B16 article-title: Nomograms to Predict Recurrence-Free and Overall Survival After Curative Resection of Adrenocortical Carcinoma publication-title: JAMA Surg doi: 10.1001/jamasurg.2015.4516 |
SSID | ssj0000650103 |
Score | 2.336076 |
Snippet | This study focused on developing an effective nomogram for improving prognostication for patients with primary nasopharyngeal carcinoma (NPC) restaged... ObjectiveThis study focused on developing an effective nomogram for improving prognostication for patients with primary nasopharyngeal carcinoma (NPC) restaged... |
SourceID | doaj pubmedcentral proquest pubmed crossref |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | 594363 |
SubjectTerms | nasopharyngeal carcinoma nomogram Oncology prognostic prediction serum biomarkers survival |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1La9wwEBYlh9JL6bvuCxV66cFdWw_LPiahIRR2CTSluRk9G0Mil13vIX8iv7kzlrOsS2kvPdqWLaH5rPkGjb4h5AOwBC28xOz-4HMRXMi1ciIPBrw_UAqrSjzgvFxVp9_Elwt5sVfqC3PCkjxwmriFEaOCXql8VYigYfG0rHDWmNqUzJvxHDn4vL1gKq3BEgsYpH1JiMKaRegjKhay4pNsBK_4zA-Ncv1_4pi_p0ru-Z6TR-ThRBrpYRrsY3LPxyfk_nLaFn9Kbg_pqr8eE63oEbglR_tIYRXYwmXXX2MGznpDdXR0kgG9osdzoWY69PRsjR8c6NctLB8AQNpFepZkVzf0ezdcQicxX_pB4ymkztKVxhoIen0Tf3j8JJYlitDdM3J-8vn8-DSfCi3kVlRsyEvc2-OGM86lZr6sQlGrAH7MuiIwGbzmAmhHbSA-M0BwA7CC4KSTtfOKS_6cHMQ--peENiH4SgEwRGOEZYADK5QQQleo-1W7jCzuZr21kwg51sK4aiEYQTu1aKcW7dQmO2Xk4-6Nn0mA4y9tj9CQu3YonT3eAEC1E6DafwEqI-_vYNDCr4b7Jzr6frtpmVAc-G1dVRl5kWCx64pz6B_4TkbUDDCzscyfxO5ylPNWELKJpn71Pwb_mjzA-cB8m7J4Qw6G9da_BdY0mHfjD_ILoc8Xbg priority: 102 providerName: Directory of Open Access Journals |
Title | A Nomogram Based on Serum Biomarkers and Clinical Characteristics to Predict Survival in Patients With Non-Metastatic Nasopharyngeal Carcinoma |
URI | https://www.ncbi.nlm.nih.gov/pubmed/33363024 https://www.proquest.com/docview/2473405866 https://pubmed.ncbi.nlm.nih.gov/PMC7758498 https://doaj.org/article/b47134917e604fa990c20dcbb8b12eb7 |
Volume | 10 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELagSFUviDfhURmJC4e0iR9x9oBQW1EqpF1VohV7i-zYbiNtHchmJfon-M3MJNmFoIVLoiSOnWTGnm_i8TeEvAWUoIWTGN3vXSy89bFWVsTegPUHSFGqFBc4T2fZ2aX4PJfz38ujhw-43OraYT6py2Zx8OP77Qfo8O_R4wR7e-jrgGSELDmQE8EzfpfcA7ukMJ_BdAD7_bgsMakBZptjXMRQdN7PW26tZI_scg77hImRyeqY_bfB0b-jKv8wU6cPyP0BX9KjXiEekjsuPCK702EG_TH5eURn9U0Xk0WPwYJZWgcKA8YKDqv6BoN1miXVwdKBMXRBT8aczrSt6XmDFbb0ywpGGtBVWgV63jO0LunXqr2GRkI8da3GBUtVSWca0yXo5jZcOawSMxgFaO4JuTj9eHFyFg85GeJSZKyNU5wG5IYzzqVmLs18kisPJq-0iWfSO80FIJTcgCtnAAt7ABDeSitz6xSX_CnZCXVwzwmdeO8yBTokJkaUDFSmFEoIoTOkCMttRA7XX70oB75yTJuxKMBvQZEVKLICRVb0IovIu80d33qujv-UPUZBbsohy3Z3om6uiqHTFkZ07I2pclkivAbDXbLElsbkJmXOqIi8WatBAb0Sp1p0cPVqWTChOEDhPMsi8qxXi01Ta7WKiBopzOhZxldCdd0xfyvw7sQkf_HPOl-SPXxJjLdJk1dkp21W7jWgptbsd38bYPtpnu53HeMXDMgV_Q |
linkProvider | Scholars Portal |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+Nomogram+Based+on+Serum+Biomarkers+and+Clinical+Characteristics+to+Predict+Survival+in+Patients+With+Non-Metastatic+Nasopharyngeal+Carcinoma&rft.jtitle=Frontiers+in+oncology&rft.au=Li%2C+Qing-Jie&rft.au=Mao%2C+Yan-Ping&rft.au=Guo%2C+Rui&rft.au=Huang%2C+Cheng-Long&rft.date=2020-12-10&rft.issn=2234-943X&rft.eissn=2234-943X&rft.volume=10&rft.spage=594363&rft_id=info:doi/10.3389%2Ffonc.2020.594363&rft_id=info%3Apmid%2F33363024&rft.externalDocID=33363024 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2234-943X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2234-943X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2234-943X&client=summon |